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Abstract 
Blood serum from 154 volunteers at 13 UK locations in 2003 were analysed for a range of 
PCBs, organochlorine pesticides and PBDEs. HCB, p,p’-DDE and p,p’-DDT and β-HCH 
were the dominant organochlorine pesticides in most samples. BDEs 47, 99, 100, 153, 154 
and 183 were the most regularly detected PBDEs. This study is the first report of BDE209 in 
UK human blood (found in 11 samples, range <15-240 ng/g lipid). Concentration and age 
correlated for the less easily metabolised PCBs, p,p’-DDT and p,p’-DDE, HCB and HCHs. 
With increasing age females tended to have lower concentrations of the more chlorinated 
PCBs than males. Similar PBDE concentrations, and distributions, to those reported in the 
general population in Sweden in 2002 were found, despite differences in historical PBDE 
production and usage. There is increasing regulation to control persistent and bioaccumulative 
chemicals, and establishing human exposure will help to identify substances which should be 
urgently phased out. 
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Capsule: A survey of PBDE, PCB and OC pesticide concentrations in human blood helps 
identify baseline concentrations in the UK population and found decabromodiphenyl ether in 
non-occupationally exposed individuals. 
KEYWORDS: Polychlorinated biphenyl, chlorinated pesticides, polybrominated diphenyl 
ether, brominated flame retardants, serum 
 
Introduction 
Humans are exposed to man-made chemicals from a variety of environmental sources. Non-
occupational exposure of the general human population to a range of man-made lipophilic 
organic chemicals, such as those classed as ‘persistent organic pollutants’ (POPs), and similar 
chemicals, has been of increasing concern over the last several decades. This concern is based 
on the realisation that chemicals with these properties can have serious effects in wildlife and 
humans, and moreover, that once such effects become apparent, ongoing exposure cannot be 
prevented in the short term. Concern is also linked to the realisation that many chemicals have 
been inadequately tested for their safety and the increasing sophistication of toxicology.  In 
particular, there is increasing evidence that environmentally relevant concentrations of some 
chemicals may have measurable toxic (e.g. endocrine effects) and genotoxic effects in 
humans and other animals (Golden et al., 1998; Oberdörster and Cheek, 2000; Legler and 
Brouwer, 2003; Welshons et al., 2003; Kalantzi et al., 2004a; Kalantzi et al., 2004b). This 
concern is also fed by the ability to demonstrate widespread contamination because of the 
increasing sophistication and sensitivity of analytical techniques and instruments. 
Some organochlorine pesticides (OCPs) were banned or restricted in North America and 
Europe in the 1970s, but some, such as DDT and HCHs continue to be used in some 
countries. After widespread commercial and industrial use in a great variety of products, the 
production of polychlorinated biphenyls (PCBs) was banned in many countries in the 1970s. 
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However, PCBs are still in service in capacitors and transformers in many countries, although 
the Stockholm Convention contains provisions to help ensure the safe disposal of existing 
stocks, and requires that countries aim to eliminate discharges of PCBs formed as by-
products. The persistence of PCBs and other POPs means that they are still present, and 
mobile, in the environment, despite the international restrictions agreed under the Stockholm 
Convention. 
Two of the three main polybrominated diphenyl ether (PBDE) commercial mixtures (known 
as pentaBDE and octaBDE) were banned from the European market in 2004.  These products 
are now also facing bans in several states in the US, and will be removed from the North 
American market by 2008. However, many products containing these chemicals are still in 
use, and many end their useful lives in land-fill sites, from where PBDEs may be able to enter 
the wider environment. Strict furniture fire resistance laws in the UK and some states of the 
USA (e.g. California) have meant that pentaBDE was probably used more extensively in 
polyurethane foam products in these countries. A third commercial BDE mixture, 
decabromodiphenyl ether (decaBDE), is used in high-impact polystyrene for electronic 
enclosures and as a flame retardant in upholstery textiles (Hardy, 2002) at an estimated rate of 
56,100 tonnes, in 2001, worldwide (Voorspoels et al., 2003). 
The general human population is predominantly exposed to PCBs and OCPs through 
foodstuffs (Duarte-Davidson and Jones, 1994) but a significant proportion of certain PBDE 
mixtures may enter humans through the inhalation of dust or vapour-phase PBDEs in the 
indoor environment (Bergman et al., 1997; Sjödin et al., 2001; Wilford et al., 2004). Human 
exposure to these chemicals has generally been investigated by analysing the chemicals of 
interest in a variety of tissue samples. This gives what could be viewed, simplistically, as an 
‘integrated’ view of the exposure of the subject, since lipophilic chemicals are predominantly 
stored in the lipid deposits of the body, found throughout most tissue types. However, the 
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mechanisms of uptake and storage of these chemicals are not well understood, and indeed 
neither the mechanism, nor the efficiency, of absorption of these chemicals across the human 
gastro-intestinal tract has been characterised to a satisfactory degree (Kelly et al., 2004). 
There are many complicating factors which impact on the chemical concentrations measured 
in the tissue of a subject, including: individual biological variation; temporal exposure pattern 
(e.g. sporadic, evenly distributed, or following a smoothly changing curve over the subject’s 
life); lifestyle and personal factors (e.g. age, children carried and breastfed, habits and diet, 
current body-mass index and changes in this over time). The differences in chemical 
behaviour in people with only slight differences in the characteristics outlined above can be 
appreciated from reports of both net absorption and net excretion of individual PCB 
congeners in adult male humans under similar conditions (e.g. Juan et al., 2002). 
Man-made lipophilic chemicals are present in all tissue types that have been investigated, and 
it has been shown that, with the general exception of the brain, liver and kidneys, different 
tissues contain similar concentration of these chemicals, when expressed on a fat weight basis 
(Mussalo-Rauhamaa, 1991; Schecter et al., 1991; Schecter et al., 1998; Wingfors et al., 1998; 
Aylward et al., 2003). 
A range of study designs has been used to investigate chemical concentrations in human 
populations in the past, and these have used a variety of sample media, including: tissues from 
cadavers (Duarte-Davidson et al., 1994b; Quintana et al., 2004); milk from nursing mothers 
(Schoula et al., 1996; Harris et al., 1999a); blood (Mussalo-Rauhamaa, 1991; Wingfors et al., 
1998); hair (Tsatsakis and Tutudaki, 2004); and adipose and other tissues by biopsy or from 
resectional surgery (Covaci et al., 2002a; Quintana et al., 2004). Sampling human tissues 
gives rise to issues related to patient care and ethical considerations, and each tissue which 
can be sampled has advantages and disadvantages. Blood has distinct advantages over other 
tissues for survey studies because it is relatively easy to sample. It is also relatively easy to get 
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ethical approval and to recruit volunteers. Blood can be taken from people of all backgrounds 
and ages and, importantly, from both sexes, and does not necessarily preclude or augment the 
inclusion of volunteers with illnesses. In taking blood samples, however, care should be taken 
to exclude the effects of recent meals on chemical concentrations in the blood. In addition, the 
low lipid concentration, and complex matrix, can lead to difficulty in achieving sufficient 
analytical sensitivity. 
It is important to have knowledge of the distribution of pollutant concentrations within a 
population, so that changes can be monitored, and comparisons drawn.  In Europe and North 
America concentrations of PCBs and OCPs in human tissues have generally been declining 
since the 1970s (Norén and Meironyté, 2000; Sjödin et al., 2004). Concentrations of PBDEs 
in human tissues are currently changing in different ways in different regions - for example, it 
appears that PBDE concentrations are reaching a plateau in Sweden, but may still be rising in 
North America (Ryan et al., 2002; Sjödin et al., 2004). Concentrations of PBDEs found in 
human milk from the UK have recently been reported to be substantially lower than 
concentrations found in the USA, but somewhat higher than Finland, Japan and Sweden 
(Kalantzi et al., 2004c). We have also found statistically different concentrations of PCBs, 
OCPs and BDE47 in human milk samples taken between 2001 and 2003 in two regions of the 
UK (Kalantzi et al., 2004c). 
In this study we determined PCBs, OC pesticides and PBDEs in blood from 154 people, in 13 
cities and towns, in the UK. The volunteers represented a wide range of ages, socio-economic 
backgrounds, occupations, and lifestyle patterns. A range of lifestyle, occupation and personal 
factors may influence chemical exposure and concentrations in an individual, so the responses 
to questions on these parameters were investigated. 
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Materials and Methods 
Methodological tests 
Before samples were taken for the survey a range of methodological tests were performed to 
optimise the study design. In order to determine the optimum amount of blood required for 
analysis of the target compounds a large (approx. 80 g) blood serum sample was prepared for 
analysis using the analytical methods detailed below. To determine the analytical variability, 
and whether the preferred sampling medium should be plasma or serum, one volunteer gave 
three samples of serum and three of plasma. Procedural blanks, consisting of blood collection 
tubes (Vacutainers®) filled with purified water, were treated and analysed as samples, to 
investigate whether the collection tubes contaminated the samples with the chemicals of 
interest. Analytical blanks consisted of purified water. 
There was no statistical difference, for any chemical group or individual chemical, between 
serum and plasma, on either a whole weight or an extracted lipid weight basis, so either could 
be chosen as the sampling medium. However, the plasma BD Vacutainers®, treated with 
lithium heparin, showed detectable concentrations of PCBs, whereas the serum BD 
Vacutainers® showed no detectable concentrations of the chemicals of interest. Therefore, 
serum was chosen as the sampling medium. From the results of the large blood sample, 10 g 
was chosen as the practical amount of serum to extract and prepare for analysis, which 
allowed the dominant constituents of each chemical class (CBs 28, 74, 118, 153, 180, 194; 
p,p’-DDT; p,p’-DDE; HCB; β-HCH; BDEs 47, 99, 153 - each PCB or PBDE congener 
representing a halogenation level) to be reliably detected (at least 10 times the standard 
deviation of the blank, or 3 times the detection limit, in the absence of blank concentrations). 
The analytical variability, based on concentrations expressed per g lipid in serum, was close 
to 30% (RSD - relative standard deviation) for all analytes. 
Choice of volunteers and ethical approval 
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154 volunteers provided samples, between 9 and 19 (median 11) volunteers from each of 13 
locations in the UK. The volunteers were sampled in Belfast, Birmingham, Cardiff, 
Edinburgh, Exeter, Godalming, Huntingdon, Leeds, London, Manchester, Newcastle-upon-
Tyne, Nottingham and Winchester (see Figure 1 for locations), however, they did not 
necessarily live in these towns.  Of the volunteers, 50 were male and 104 female and the 
median age was 40.5 (range 22 to 80). The body mass index (BMI) ranged between 17.7 and 
42.8 (median 23.4). 1 volunteer was vegan, 19 vegetarian, 23 predominantly vegetarians who 
also ate fish, and 110 were omnivores. 54 of the female volunteers had not had a child, 11 had 
one, 18 had 2 children, 10 had 3, and 6 had 4 or more children. The majority of women 
breastfed all of their children.  
The only selection criteria for volunteers were that they were over 18 years old, weren’t 
knowingly pregnant or had any illness or heart condition that might increase the risks 
associated with having a sample of blood taken.  The volunteers were sampled during the day, 
mostly on week days, which might have selected against people at work.  No claim is made 
about the representativeness of the sample to the general adult population, but the higher 
proportion of women and vegetarians sampled might suggest that the self-selecting group is 
not truly representative. 
Sample collection 
Blood samples were taken by medical professionals in March, June and July 2003. 40 ml 
whole blood was taken from each volunteer. Volunteers were asked not to take a meal, or 
drink any milk, for at least several hours before the samples were taken so that their blood- 
lipid chemical concentrations should represent their ‘stable’ levels (unaffected by recent 
ingestion). Blood samples were taken into BD Vacutainer® serum tubes (with clotting agent 
and polymer separator). Samples were mixed by inverting the tubes several times 
immediately after blood collection, and, after 10-15 minutes, centrifuged at 3000 rpm for 10 
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min, to separate the serum from the blood cells. Samples were immediately frozen and 
transported to the laboratory. All samples were still frozen upon receipt at the laboratory, 
where they were defrosted and the serum transferred to clean glass containers before being 
frozen at –20 °C until analysis. 
Analysis 
Sample analysis was performed at Lancaster University using methods based on those 
developed by Hovander et al. (2000), briefly entailing denaturation of the sample with 
hydrochloric acid and propan-2-ol, followed by extraction with a hexane:MTBE mixture. 
Samples were then cleaned using concentrated sulphuric acid, followed by gel permeation 
chromatography (Biobeads S-X3), before the addition of internal standards (CB30, 13C12-
labelled CB141 and 13C12-labelled CB208), final volume reduction, and analysis by GC-MS. 
Samples were analysed for 43 PCBs (CBs 18, 22, 28, 31, 41/64, 44, 49, 52, 54, 70, 74, 87, 
90/101, 95, 99, 104, 105, 110, 114, 118, 123, 138, 141, 149, 151, 153, 155, 156, 157, 158, 
167, 170, 174, 180, 183, 187, 188, 189, 194, 199 and 203) and 12 organochlorine pesticides 
(α- and γ-chlordane, HCB, o,p’- and p,p’-DDD, o,p’- and p,p’-DDE, o,p’- and p,p’-DDT, and 
α-, β- and γ-HCH) using a Finnigan TRACE GC- MS. The gas chromatograph used splitless 
injection and was fitted with a 50 m CPSil8 capillary column. The mass spectrometer used an 
electron impact (EI+) source in selected ion monitoring (SIM) mode, monitoring the relevant 
molecular ion m/z ratios for PCBs and dominant fragments for OCPs. 
21 PBDEs (BDEs 17, 28, 32, 35, 37, 47, 49, 71, 75, 77, 85, 99, 100, 119, 138, 153, 154, 166, 
181, 183 and 190) were analysed using a Fisons MD800 GC-MS. The GC used splitless 
injection and was fitted with a 30 m DB5 capillary column. The MS used a negative ion 
chemical ionisation (NICI) source in SIM mode, and used ammonia as the reagent gas, 
monitoring m/z ratios 79 and 81 for the PBDEs. 
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BDE209 was analysed using a Micromass Autospec Ultima GC-HRMS in EI mode, using a 
resolution of at least 10,000, tuned using perfluorokerosene (PFK). The GC used cool 
on-column injection and was fitted with a 15 m DB5 capillary column. The MS used an EI+ 
source in selected ion monitoring (SIM) mode, monitoring m/z ratios 797.3355 and 799.3334 
for BDE209 and m/z ratios 809.3757 and 811.3737 for 13C-labelled BDE209. 
Quality control 
PCBs and OCPs were analysed using CB30 and 13C-CB141 as internal standards, while 
PBDEs were analysed using 13C-CB141 and 13C-CB208 as internal standards. All samples 
were spiked with 13C-labelled recovery standards (6 ng total), in 25 µl acetone, before 
extraction. The standards included 13C12-labelled CBs 28, 52, 101, 138, 153, 180 and 209 and 
13C12-labelled BDE209. Concentrations were not corrected for the recoveries of these 
standards, but the recoveries were monitored to assess the effectiveness of the analytical 
methods. 13C-labelled PCB recoveries averaged 79-84 % and 13C-labelled BDE209 recovery 
averaged 107%. 
One laboratory blank, consisting of purified water, was analysed for every 10 samples 
analysed, and average blank concentrations were subtracted from the concentrations found in 
each sample before application of the detection limit. 
Control samples, consisting of the BD Vacutainer® tubes used for sample collection were 
prepared using purified water. After drawing the water into the tube the water was decanted 
and treated as a normal sample for analysis. One control sample was prepared for each 25 
blood samples analysed. 
One in-house reference material, consisting of an equivalent amount of homogenised seal 
blubber lipid to that which was normally extracted from a blood sample, was analysed for 
each 25 blood samples. Concentrations of selected analytes were compared to a control chart 
based on previous analyses of the reference material. They did not exceed the specified upper 
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or lower action limit concentrations, which were defined as the mean ± 3 times the standard 
deviation. 
Detection limits 
For chemicals detected in the blank samples the method detection limit was defined as three 
times the standard deviation of the blank value. In the absence of detectable concentrations in 
the blank samples the method detection limit was defined as the instrument detection limit. 
Method detection limits were typically (in ng/g lipid) 0.6 for PCBs, 0.9 for OCPs, 0.2 for 
PBDEs (excluding BDE209) and 36 for BDE209. The relatively high detection limit obtained 
for BDE209 is due to a combination of the instrument detection limit and the concentrations 
which were found in the analytical blanks. 
Questionnaire 
A questionnaire, completed by each volunteer, included a range of questions relating to 
personal characteristics, habits, lifestyle and their home. The questionnaire results were 
transferred into a spreadsheet, and, where appropriate, processed and categorised to a small 
number of discrete bands. Questionnaire data used in the statistical analysis included: age; 
gender; body mass index (BMI); current weight trend (gaining/losing/stable); sampling 
location (i.e. place of main residence); age of main residence; type of area resided in 
(urban/rural); areas previously resided in; visits to malarial countries; new furniture/carpet 
purchases (in the last decade); general diet (omnivore, vegetarian, vegan, fish consumption); 
consumption of organic foodstuffs; number of children carried; number of children breastfed; 
main occupation type; computer usage (hours per day). 
The entire data-set, formed by the chemical concentration data and the questionnaire data, was 
analysed using the ‘SPSS’ statistical software package. 
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Results and discussion 
The chemical concentrations found in the serum samples are summarised in Table 1. There is 
evidence, as expected in biological samples, that the concentrations do not conform to a 
Normal distribution (see later discussion), so the data has been summarised using the median, 
ranges and quartile values. It should be noted that the LOD is calculated by dividing the 
method detection limit (ng or pg per sample) by the weight of sample analysed, and is 
therefore different for each sample. Values below the LOD are treated as being zero for 
calculating total chemical group concentrations (i.e. ‘Total PCB’ etc.). 
We believe this study represents the most comprehensive survey of organohalogen chemicals 
in humans in the UK in at least the last 10 years, and includes the first report of PBDEs in 
human blood serum samples from the general population in the UK. 
PCB, organochlorine pesticides and PCDD/F concentrations have been shown to be similar, 
when expressed as concentration per g lipid, in human adipose and blood serum or plasma 
(Mussalo-Rauhamaa, 1991; Schecter et al., 1991; Wingfors et al., 1998) and also, for PCBs, 
between human milk and blood (Schecter et al., 1998). It is likely that most PBDEs also 
follow this pattern because they have similar physical-chemical properties to the other 
chemicals studied. We have, therefore, included published concentrations in human adipose 
and milk in further discussion, since there is a lack of human serum concentration data in the 
literature for some of the chemicals tested. 
PCBs 
The total PCB concentrations (defined as the sum of all congeners detected) ranged from 14 
to 670 ng/g lipid, with a median of 170 ng/g lipid. As expected, CBs 153, 180 and 138 (in that 
order) were the dominant congeners, each contributing more than 10% to the median total 
PCB concentration. 
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Previously published concentrations of PCBs in the western European population are 
summarised in Table 2. Only data with acceptable data presentation (i.e. range and median or 
geometric mean - the arithmetic mean concentration alone is not useful for samples with non-
Normal distributions) have been used for this comparison. All published studies of PCBs in 
the UK population are included. It can be seen that the median total PCB serum concentration 
in 2003 is approximately five times lower than the concentration in adipose taken from 
(predominantly male) corpses in Wales in 1990/91 (Duarte-Davidson et al., 1994b) and 
approximately 2.5 times lower than in milk-fat samples from Wales in the same period 
(Duarte-Davidson et al., 1994a). The range of total PCB concentrations is somewhat broader 
in relation to the median in this study than was found in either of the Welsh studies. Since it 
has been shown that human exposure to PCBs is predominantly through the diet (Duarte-
Davidson and Jones, 1994), the decrease in PCB concentration since 1990/1 is likely to be 
due to a reduction in environmental (and particularly human foodstuffs) concentrations over 
the past decade. 
The median and range of values found in this study are, however, very close to those found in 
human breast milk-fat collected in London and Lancaster between December 2001 and 
January 2003 (Kalantzi et al., 2004c). The median total PCB concentration found in this study 
is 2 to 3 times lower than found in studies of human serum (from women aged 50-65 (Koppen 
et al., 2002) and from pregnant women (Covaci et al., 2002b) in Belgium) and adipose from a 
varied population (Chu et al., 2003) in other European studies (between 1991 and 2002). The 
range of concentrations found in this study has the same upper limit, but a substantially (by a 
factor of 8 or more) smaller lower limit than found in the other European studies (see Table 
2). The cause of the difference in PCB concentrations between this study and those in these 
mainland European countries cannot be determined, but may be related to different dietary or 
agricultural practices, or different characteristics of the sample populations. 
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Organochlorine pesticides 
Of the organochlorine pesticides analysed HCB, p,p’-DDE, p,p’-DDT and β-HCH were most 
commonly detected and were dominant in almost all samples.  α-Chlordane and γ-chlordane 
were not detected in any of the samples analysed.  
The range of concentrations found for HCB was relatively small, whilst the range of 
concentrations found for p,p’-DDE was the largest of any chemical analysed. The median 
concentrations of HCB, p,p’-DDE, p,p’-DDT and β-HCH were very close to median 
concentrations found in milk samples taken from London and Lancaster between 2001 and 
2003 (Kalantzi et al., 2004c) although the ranges of values found for HCB and β-HCH in this 
study are slightly narrower. Organochlorine pesticide concentrations found in other studies of 
western Europeans are summarised in Table 3. It can be seen that p,p’-DDE concentrations 
found in this study are between a factor of 1.1 and 9.9 lower than found in other studies 
conducted since 1990, and in particular that concentrations are somewhat lower than recently 
found in Belgium. Again, the cause of the difference in concentrations between this study and 
the other studies cannot be determined. HCB concentrations in this study were rather lower 
than found in the UK in 1997 or in Belgium in 1999, and β-HCH concentrations in this study 
were rather lower than found either in the UK in 1997. 
o,p’-DDD, o,p’-DDT, o,p’-DDE, p,p’-DDD, α−HCH and γ−HCH were detected in few 
samples. In all cases the p,p’-DDE concentration greatly exceeded (almost always by more 
than an order of magnitide) the p,p’DDT concentration, indicating that exposure to the DDT 
pesticide was either indirect (e.g. through the diet) or historical. In seven cases, however, the 
concentration of p,p’-DDE was less than ten times the concentration of p,p’-DDT, which may 
indicate more recent exposure. Six out of these samples came from volunteers who had spent 
time in areas where malaria is prevalent (and where DDT may still be in current use), 
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although other volunteers who had also spent time in malarial areas did not show increased 
DDT/DDE ratios. 
PBDEs 
BDEs 47, 99, 100, 153, 154 and 183 were regularly detected. All of these, except BDE183, 
are constituents of pentaBDE commercial products, whereas BDEs 153 and 183 are 
constituents of the octaBDE commercial product. Neither product is now used in the 
European Union (Renner, 2004). The median concentration of BDE153 was higher than the 
median concentration of BDE47, which is unusual compared to other published data on 
humans, but was also found in Belgian adipose samples (Covaci et al., 2002b) and in serum 
from some occupational groups in Sweden between 1997 and 2000 (Jakobsson et al., 2003). 
A similar pattern was found in milk-fat samples from Lancaster in the UK taken between 
2001 and 2003 (Kalantzi, 2004). The values and the distribution of the concentrations of the 
sum of BDEs 47, 99, 100, 153 and 154 were very similar to that found in Swedish blood 
samples taken from the general population (van Bavel et al., 2002), with approximately 5% of 
samples from this UK study and the Swedish study having concentrations higher than 30 ng/g 
lipid (more than five times the median value). High concentration ‘outlier’ samples have also 
been noted in a number of separate studies of PBDEs in humans (Hites, 2004). This may 
indicate that there is a ‘normal PBDE exposure’ population and a ‘higher PBDE exposure’ 
population within each country, but the source of the higher exposure is not evident from the 
personal information provided. Another possibility is that some individuals have markedly 
different capacities to metabolise and/or excrete PBDEs (for example, human polymorphism 
in cytochrome P-450 isoenzymes has been documented (e.g. Bolt et al., 2003)).  
BDE209, the predominant congener in the deca-BDE commercial product, was found in 11 
samples, ranging in concentration from close to the detection limit (3 samples) to a maximum 
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of 240 ng/g lipid (230 pmol/g lipid). It is likely that improvements in the detection limit will 
result in BDE209 being found in a higher proportion of samples. 
PBDE concentrations in humans in western Europe and North America have been 
summarised in Table 4. It can be seen that the total PBDE concentrations found in this study 
are very similar to concentrations found in other European countries in recent years, and 
rather higher than were found in the late 1970s and early 1980s in Scandinavia. Median total 
BDE concentrations in the UK are approximately ten times lower than recently found in 
North America (She et al., 2002; Mazdai et al., 2003; She et al., 2004), although the 
maximum BDE concentration is similar in the UK, California and Indiana, and the minimum 
value is similar in the Pacific North-West of America and the UK. Both the UK and 
California have very strict fire resistance laws for furniture which is likely to have led to 
greater exposure of the general population to the pentaBDE product (previously used to treat 
polyurethane foam for furniture) than people living in other countries or states. This appears 
not to have led to higher median serum concentrations in the UK, although the range of 
detected values is broader than in other countries – perhaps because a small number of people 
may have particularly high exposure to these chemicals, either at home or through their 
occupation. BDE183 (indicative of octaBDE) was found in this study at a similar median 
concentration, and with a similar range, to recent studies in Sweden (Jakobsson et al., 2003) 
and North America (Mazdai et al., 2003; She et al., 2004), whereas we found BDE209 
(indicative of decaBDE) at a higher median concentration than was found in Sweden and 
North America, but with a similar overall range of concentrations to Sweden. The highest 
BDE209 concentrations reported in the Swedish study were from occupationally exposed 
people (in the flame retarded rubber industry), and are similar to those found in the UK in this 
study, although the people with the highest concentrations in this study did not work in 
industries noted for BDE209 use (such as plastic, rubber and curtain fabric processing). 
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Statistical analysis 
As previously noted, there was evidence that the chemical concentrations did not conform to 
the Normal distribution. Q-Q plots confirmed that the data was well described by the log-
Normal distribution for all chemicals except several PBDEs (BDEs 47, 99, 100 and 153) for 
which there were a small number of ‘outlying’ points at the upper extreme of the distribution. 
Chemical concentration data were therefore transformed to their natural logarithms (ln) for 
further statistical analysis, and the tests were performed both including and excluding the 
‘outlying’ points for the relevant PBDEs. To reduce the complexity of the analysis one PCB 
was chosen to represent each chlorination level represented in the PCBs analysed (CBs 28, 
52, 118, 153, 180 and 194), six PBDEs were chosen (BDEs 47, 99, 100, 153, 154 and 183 – 
BDE209 was not detected in enough samples for statistical tests to be performed), and the OC 
pesticides which were most commonly detected (total HCH, p,p’-DDE, p,p’-DDT and HCB) 
were included. 
Highly significant correlations (Pearson correlation coefficients 0.34-0.52, significant at the 
99 % level) were found between all ‘old use’ chemicals, i.e. PCBs and OCPs, (indicating that 
they are likely to have reached the volunteers through similar exposure patterns, histories and 
routes) and between individual PBDEs. However, no significant correlations were found 
between PBDEs and either PCBs or OCPs. For further statistical analysis the chemicals were, 
therefore, represented by p,p’-DDE, total HCHs, total PCBs, HCB, BDE47, BDE183 and 
total PBDEs (BDEs 47 and 183 are retained separately because BDE183 did not exhibit 
‘outliers’ from the log-Normal distribution as BDE47 did, and because of their different 
historical usage patterns). 
Chemical concentration data were compared to categorised ‘lifestyle’ factors (age was 
grouped by decade from ages 20 to 60, using age >60 as a single group, BMI was grouped as 
<20, 20-24.9, 25-29.9 and >30) using a univariate ANOVA, removing factors stepwise until 
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all remaining factors were significant. Using this method it was found that volunteer age-
group (to a highly significant degree – 99%) and location (95%) had the greatest impact on 
total PCB concentrations, although no regional differences could be identified (i.e. significant 
differences between sampling sites did not follow any geographical, or other, pattern). 
Significantly different (99%) HCB concentrations were found in volunteers from different 
locations, with gender also having a significant impact on the differences seen. The ANOVA 
model for p,p’-DDE concentrations showed variability may be related to age (99% 
significance), and for total HCH may be related to both location and age (99% significance). 
The ANOVA model could not identify any significant differences between concentrations of 
any PBDEs which could be related to the questionnaire results. 
It is likely that the sample population in each location (median 11 individuals) is too small to 
reliably identify concentration differences between regions of the UK, although the sample 
population in London (19 males and females) was little lower than in a previous study of 
breast milk (27 females) which did show regional differences (Kalantzi et al., 2004c). 
However, principal components analysis of the HCB and HCH concentrations, based on 
location, showed that concentrations found in serum from volunteers sampled in Belfast and 
Newcastle could be substantially separated from samples from the rest of the UK (a small 
number of ‘the rest of the UK’ samples overlapped with some Belfast and Newcastle 
samples). No particular factors associated with samples taken in these cities could be found 
which might explain this observation. 
Linear regression analysis showed that many PCBs (generally excluding Cl3-4CBs), p,p’-
DDE, p,p’-DDT and HCH concentrations correlated highly significantly (at the 99% level) 
with age, and that HCB correlated significantly (at the 95% level) with age (see Table 5 and 
Figure 2 for examples). The particular PCBs which correlated well with age were CBs 74, 99, 
105, 118, 138, 153, 156, 157, 167, 170, 180, 187 and 194, and those not correlating well were 
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CBs 28 and 183, the remaining PCBs also did not correlate well with age but were detected in 
less than half of the samples. PCB metabolism in mammals is related to the chlorination 
pattern (see Strandman et al., 2000), and the easily metabolised congeners generally 
accumulate less than more persistent congeners. This could explain the lack of correlation 
between the less chlorinated PCBs and age, and similarly for some of the more chlorinated 
PCBs which are more easily metabolised due to their chlorination pattern. For persistent 
Cl6-8CBs, being female had a significant (at the 95% level) negative impact on the slope of 
this regression (see Figure 2 – CB180) i.e. with increasing age females tended to have lower 
concentrations than males. Since we do not expect a difference in exposure, or metabolism, 
between males and females in the general population, we presume that this is related to the 
transfer of chemical to children during gestation and lactation, which is indirectly related to 
age, as that is the only major excretion route different between females and males. However, 
significant correlations between chemical concentrations in females and the number of 
children carried (or breast fed) were not found. 
Concluding remarks 
This study was, we believe, the first survey of blood serum concentrations of PCBs, 
organochlorine pesticides and PBDEs in the UK. The data-set produced may be seen as an 
indicator of human concentrations of this range of chemicals in the UK, although it cannot be 
considered representative of the UK population in general. In particular, we have shown a 
correlation between age and concentrations of the following chemicals: persistent PCBs; p,p’-
DDT; p,p’-DDE; HCB; HCHs. For the more chlorinated persistent PCBs we have also shown 
a significant difference in the age related concentration difference between males and females. 
We have also found that the UK population in 2003 had similar PBDE concentrations, and a 
similar concentration distribution, to that found in the general population in Sweden in 2002, 
with approximately 5% of the population having more than five times the median PBDE 
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concentration, which may indicate a sub-population, in both countries, which is more exposed 
to these chemicals than the general population. This is somewhat surprising because of the 
history of PBDE production and use in the UK compared to Sweden. We report BDE209 
concentrations in humans in the UK for the first time, with a similar overall range of 
concentrations to that found in Sweden recently, although, in contrast to the Swedish study, 
the people with the highest concentrations in this study did not work in industries noted for 
BDE209 use. 
There is increasing regulatory pressure to control persistent and bioaccumulative chemicals 
more effectively - for instance in the forthcoming European Union ‘REACH’ chemicals 
legislation, and under the Stockholm Convention on persistent organic pollutants. 
Establishing levels of contamination in humans and wildlife is an important way of verifying 
the environmental behaviour of chemicals approved for use. Such monitoring helped to 
identify penta- and octa-BDE as priorities for banning in the EU, and their proposed addition 
to the list of POPs. Further monitoring will be useful to determine the effect of the EU ban on 
human exposure to these chemicals compared to, for instance, the US where restrictions on 
PBDE use have been introduced more recently. 
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Table 1 –  Summary of PCB concentrations found in blood serum  
 Median Range 1st/3rd Quartiles Nb 
 ng/g lipid ng/g lipid ng/g lipid  
CB 18 <0.38  <0.38-2.9 <0.38/<0.38 15 
CB 22 <0.33  <0.33-4.8 <0.33/<0.33 19 
CB 28 2.1  <1.0-14 1.2/3.0 128 
CB 31 <0.36  <0.36-10 <0.36/0.95 55 
CB 41/64 <0.24  <0.24-21 <0.24/<0.24 20 
CB 44 <0.24  <0.24-1.6 <0.24/<0.24 28 
CB 49 <0.38  <0.38-3.9 <0.38/<0.38 30 
CB 52 <0.25  <0.25-4.7 <0.25/0.5475 67 
CB 54 <0.24  <0.24-0.5 <0.24/<0.24 1 
CB 70 <0.24  <0.24-19 <0.24/0.58 54 
CB 74 4.0  <0.3-27 2.2/8 144 
CB 87 <0.24  <0.24-57 <0.24/<0.24 12 
CB 90 + 101 <1.3  <1.3-9 <1.3/<1.3 13 
CB 95 <0.98  <0.98-9 <0.98/<0.98 17 
CB 99 3.1  <3.3-17 2.1/5.1 153 
CB 104 <0.24 NA NA 0 
CB 105 1.0  <0.29-6.5 <0.29/2.1 114 
CB 110 <0.32  <0.32-2.1 <0.32/<0.32 6 
CB 114 0.16  <0.25-9.2 <0.25/0.81 77 
CB 118 6.1  <0.52-29 3.5/10 153 
CB 123 <0.24  <0.24-0.66 <0.24/<0.24 4 
CB 138 27  <7.1-110 18/47 149 
CB 141 <0.67  <0.67-3.6 <0.67/<0.67 5 
CB 149 <4.1  <4.1-12 <4.1/<4.1 8 
CB 151 <1.6  <1.6-6.7 <1.6/<1.6 10 
CB 153 41  <9.3-200 28/70 152 
CB 155 <0.24 NA NA 0 
CB 156 4.6  <0.41-18 3/7.7 151 
CB 157 1.1  <0.25-3.8 0.48/1.7 121 
CB 158 <0.28  <0.28-5 <0.28/0.62 68 
CB 167 1.65  <0.3-6.1 0.9/3 134 
CB 170 13 <2.6-61 8/21 150 
CB 174 <0.65  <0.65-6.8 <0.65/<0.65 9 
CB 180 33  <4.7-200 20/53 151 
CB 183 3.0  <0.91-16 <0.91/5 104 
CB 187 6.6  <2.1-57 3.3/11 129 
CB 188 <0.24 NA NA 0 
CB 189 <0.24  <0.24-1.2 <0.24/<0.24 8 
CB 194 5.1  <0.61-39 2.5/8 147 
CB 199 <0.24 NA NA 0 
CB 203 <2.8  <2.8-37 <2.8/5.8 71 
Total PCB  170 14-670 100/270 154 
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Table 1 cont’d 
 Median Range 1st/3rd Quartiles Nb 
 ng/g lipid ng/g lipid ng/g lipid  
α- chlordane <0.48 NA NA 0 
γ- chlordane <0.48 NA NA 0 
HCB 11  <4.8-72 <4.8/20 108 
o,p’- ddd <0.48  <0.48-49 <0.48/<0.48 13 
o,p’- dde <0.48  <0.48-3.9 <0.48/<0.48 7 
o,p’- ddt <0.51  <0.51-8.4 <0.51/<0.51 19 
p,p’- ddd <0.51  <0.51-20 <0.51/<0.51 8 
p,p’- dde 100  <11-2600 59/200 153 
p,p’- ddt 2.9  <0.64-73 1.6/5.1 140 
Total DDX* 100  1.3-2600 61/210 154 
     
α-HCH <0.48  <0.48-23 <0.48/<0.48 23 
β-HCH 12  <0.68-80 7/22 151 
γ-HCH <1.7  <1.7-110 <1.7/<1.7 17 
Total HCH 15  <8.9-120 7.8/29 154 
     
BDE 17 <0.13  <0.13-0.3 <0.13/<0.13 2 
BDE 28 <0.14  <0.14-10 <0.14/0.2 42 
BDE 32 <0.16  <0.16-11 <0.16/<0.16 16 
BDE 35 <0.12  <0.12-1.1 <0.12/<0.12 3 
BDE 37 <0.12  <0.12-0.4 <0.12/<0.12 4 
BDE 47 0.82  <0.30-180 <0.3/1.9 105 
BDE 49 <0.13  <0.13-1.7 <0.13/<0.13 3 
BDE 71 <0.12  <0.12-0.3 <0.12/<0.12 1 
BDE 75 <0.12  <0.12-0.3 <0.12/<0.12 1 
BDE 77 <0.12  <0.12-17 <0.12/<0.12 6 
BDE 85 <0.13 <0.13-5.3 <0.13/<0.13 4 
BDE 99 <0.16 <0.16-150 <0.16/0.93 63 
BDE 100 0.76 <0.17-390 0.53/1.1 142 
BDE 119 <0.12 <0.12-1.4 <0.12/<0.12 5 
BDE 138 <0.13 <0.13-1.5 <0.13/<0.13 3 
BDE 153 1.7 <0.26-87 1.2/2.4 152 
BDE 154 0.60 <0.15-4.4 0.37/0.84 132 
BDE 166 <0.12 <0.12-2.9 <0.12/<0.12 2 
BDE 181 <0.12 <0.12-0.9 <0.12/<0.12 1 
BDE 183 0.30 <0.14-1.8 <0.14/0.62 84 
BDE 190 <0.12 NA NA 0 
BDE 209 <15 <15-240 <15/<15 11 
Total PBDE 5.6 0.63-420 3.6/9.6 154 
Total DDX = sum of o,p’-DDD, o,p’-DDE, o,p’-DDT, p,p’-DDD, p,p’-DDE and p,p’-DDT; 
NA = not applicable (concentrations all below LOD); b Number of samples with 
concentrations above LOD (out of 154)
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Table 2 –  PCB concentrations previously found in tissue samples from the European 
population 







Wales, UK 1990-1 Adipose 850 (260-2600) (Duarte-Davidson et al., 
1994b) 




2001-3 Milk 180 (26-530) (Kalantzi et al., 2004c) 
UK 2003 Serum 170 (14-670) This study 
Belgium 1999 Serum 350 (110-1000)a (Covaci et al., 2002b) 
Belgium 1999 Serum 530 (450-680b) (Koppen et al., 2002) 
Belgium 2002 Adipose 480c (190-1100) (Chu et al., 2003) 
Netherlands 1991 Serum 550a,c from (Covaci et al., 2002b) 
Netherlands 1995 Serum 450 a,c  from (Covaci et al., 2002b) 
Sweden 1996 Plasma 350-640 (Norén et al., 1999) 
 
a = Calculated assuming 0.5% lipid in blood; b = 95th Percentiles; c = Arithmetic mean 
 
 29
Table 3 –  Organochlorine pesticide concentrations previously found in tissue samples from 











  Type p,p’DDE HCB β-HCH  
Wales, UK 1990-1 Adipose 990 (110-6400)   (Duarte-Davidson et al., 
1994b) 
Wales, UK 1990-1 Milk 310 (35-6000)   (Duarte-Davidson et al., 
1994a) 




2001-3 Milk 150 (22-1600) 18 (ND-180) 17 (1.2-1500) (Kalantzi et al., 2004c) 
UK 2003 Serum 100 (15-2600) 14 (5.4-72) 12 (1.9-80) This study 
Belgium 1999 Serum 310 (110-4100)a 36 (12-100)a  (Covaci et al., 2002b) 
Belgium 1999 Serum 870 (730-1200b) 110 (90-132b)  (Koppen et al., 2002) 
Belgium 2002 Adipose 480c (84-1800)   (Chu et al., 2003) 
Sweden 1996 Plasma 110-880 16-56  (Norén et al., 1999) 
 
a = Calculated assuming 0.5% lipid in blood; b = 95th Percentiles; c = Arithmetic mean 
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  Type ΣBDEa BDE183 BDE209  
London & 
Lancaster, UK 
2001-3 Milk 5.7b (0.7-28)   (Kalantzi et 
al., 2004c) 
UK 2003 Serum 4.7 (0.52-
420) 
0.59 (0.19-1.8)f 83 (35-240)g This Study 
Sweden 2001-2 Blood 4.9c,h   (van Bavel et 
al., 2002) 
Belgium 2000 Adipose 4.8c   (Covaci et 
al., 2002a) 






























  Summarised 










Serum  11 (3.0-25) ED 
<0.38 (<0.38-1.6) CB 
<0.48 (<0.48-1.1) RM 
<1.9 RW 
1.2 (0.23-6.1) CT 
0.23 (<0.02-1.3) C 
0.15 (0.029-0.37) CL 
<0.38 AB 
4.8 (<0.29-9.5) ED 
2.3 (<0.96-5.6) CB 
28 (1.2-140) RM 
34 (6.7-280) RW 
1.5 (<0.96-6.8) CT 
<0.67 (<0.67-7.7) C 
<0.67 (<0.67-3.7) CL 











  (Sjödin et al., 
2004) 
USA (CA) 1995-99 Breast 
tissue 
41 (17-462)   (She et al., 
2002) 





2003 Milk 49 (6.3-309)l 0.2 (0.006-1.6) 0.25 (0.05-1.5) (She et al., 
2004) 
 
a = sum of BDEs 47, 99, 100, 153 and 154 unless otherwise indicated; b = Geometric mean; 
c = Arithmetic mean; d = Calculated assuming 0.5% lipid in blood; e = 95th Percentiles; 
f = only detected values used (N = 85); g = only detected values used (N = 11); h = sum of 
BDE47, 99, 153; i = BDE47 only; j = sum of BDE47, 85, 99, 100, 153, 154; k = sum of 
BDE47, 99, 100, 153, 154, 183; l = sum of BDE28, 33, 71, 47, 66, 85, 99, 100, 153, 154, 183, 
209; ED = Electronics dismantlers; CB = Circuit board recycling workers; RM = Rubber 
mixers; RW = Rubber wire production; CT = Computer technicians; C = Clerks; CL = 
Cleaners; AB = Abattoir workers 
 31
Table 5 –  Regression slopes and coefficients for the relationships between chemical 
concentrations and the age of the volunteers (figures in brackets are calculated 











 Slope r2 Slope r2 Slope r2 lower slope
Chemical ng/(g lipid . year)  ng/(g lipid . year)  ng/(g lipid . year) for females
CB28 0.015 (0.015) 0.009 (0.009) -0.032 (-0.032) 0.025 (0.025) 0.025 (0.025) 0.026 (0.026)  
CB74 0.19 (0.20) 0.31 (0.40) 0.07 (0.13) 0.029 (0.25) 0.21 (0.21) 0.41 (0.41)  
CB118 0.24 (0.25) 0.33 (0.38) 0.26 (0.26) 0.32 (0.32) 0.23 (0.24) 0.32 (0.38) Y (Y) 
CB153 1.3 (1.4) 0.40 (0.43) 2.4 (2.4) 0.52 (0.52) 1.11 (1.18) 0.41 (0.48) Y (Y) 
CB180 1.1 (0.96) 0.39 (0.48) 2.1 (1.5) 0.50 (0.55) 0.89 (0.89) 0.51 (0.51) Y (Y) 
CB194 0.17 (0.17) 0.19 (0.51) 0.39 (0.30) 0.26 (0.70) 0.14 (0.15) 0.39 (0.56) Y (Y) 
HCB 0.21 (0.21) 0.043 (0.043) -0.017 (-0.017) 0.0 (0.0) 0.25 (0.25) 0.062 (0.062)  
p,p’-DDE 9.7 (7.2) 0.21 (0.34) 9.1 (8.5) 0.30 (0.37) 9.7 (7.0) 0.19 (0.32)  
p,p’DDT 0.099 (0.067) 0.032 (0.075) 0.16 (0.081) 0.066 (0.076) 0.082 (0.061) 0.023 (0.068)  
b-HCH 0.55 (0.55) 0.33 (0.33) 0.35 (0.35) 0.24 (0.24) 0.57 (0.57) 0.33 (0.33)  
BDE47 -0.16 (0.009) 0.011 (0.002) -0.29 (0.067) 0.013 (0.065) -0.11 (-0.008) 0.016 (0.002)  
BDE100 -0.19 (-0.001) 0.006 (0) -0.49 (0.016) 0.008 (0.038) -0.065 (-0.003) 0.010 (0.005)  
BDE153 -0.059 (-0.002) 0.014 (0) 0.026 (0.046) 0.013 (0.097) -0.078 (-0.006) 0.020 (0.007)  
 




Figure 1 - Map of the UK, showing sampling locations (shaded areas indicate major urban 
centres) 
Footnote: Numbered crosses indicate sampling sites - (1) Edinburgh, (2) Newcastle-upon-
Tyne, (3) Leeds, (4) Belfast, (5) Manchester, (6) Nottingham, (7) Birmingham, (8) 
Huntingdon, (9) Cardiff, (10) London, (11) Godalming, (12) Winchester and (13) 
Exeter 
 
Figure 2 – Concentration of selected chemicals plotted against age, with the genders 
differentiated 
Footnote: Results of the linear model: CB28 (Cl3CB) – no correlation with age, representative 
of metabolised and less chlorinated PCBs; CB118 (Cl5CB) – positive correlation, 
no difference between the genders; CB180 (Cl7CB) – positive correlation, 
significantly (at the 99% level) lower slope for females, representative of non-
metabolised and more chlorinated PCBs; HCB – no correlation; p,p’-DDE - 
positive correlation, no difference between the genders; Total HCH - positive 
correlation, no difference between the genders. 
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